ACTRN12610001071011
Completed
Not Applicable
Investigating predictors of the antidepressant efficacy of Transcranial Magnetic Stimulation
Professor Paul Fitzgerald0 sites120 target enrollmentDecember 6, 2010
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Professor Paul Fitzgerald
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Have a DSM\-IV diagnosis of a Major Depressive Episode (SCID II).
- •Are aged 18\-75\.
- •Have treatment resistant depression at Stage III of the Thase and Rush classification (27\).
- •Have a Hamilton Depression Rating Scale (HAMD) score of \> 20 (moderate to severe depression).
- •Have had no increase or initiation of new antidepressant (or other psychoactive) therapy in the 4 weeks prior to screening
Exclusion Criteria
- •Have an unstable medical condition, neurological disorder, any history of a seizure disorder, or are currently pregnant or lactating.
- •In the opinion of the investigator, are at sufficient risk of suicide to require immediate electroconvulsive therapy.
- •Have a current DSM\-IV diagnosis of Substance Abuse or Dependence disorder, a diagnosis of a personality disorder (SCID II) or another Axis 1 disorder.
- •Control participants will have no history of neurological or psychiatric illness and be taking no medications.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparison of Venlafaxine and Sertraline Therapeutic Effects on Depression in Patients with EpilepsyIRCT20210608051515N2Tehran University of Medical Sciences30
Not yet recruiting
Not Applicable
Clinical evaluation of the antidepressant effect of the use of probiotics in bipolar disorderRBR-5dhhhddniversidade de São Paulo
Completed
Not Applicable
Can EEG predict response to treatment in depression?Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F331- Major depressive disorder, recurrent, moderateHealth Condition 3: F321- Major depressive disorder, singleepisode, moderateHealth Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic featuresCTRI/2019/07/020290GMCH Chandigarh80
Completed
Not Applicable
Preliminary study of effect of Ketamine on depressive symptomsMental and behavioral disordersKCT0000865Ajou University Hospital40
Not yet recruiting
Phase 3
study on role of anti depression activity of ayurvedic medicinesCTRI/2022/08/044774Mahatma Gandhi Ayurveda College